See the Full Picture.
Published loading...Updated

Canadian researchers reach 'major milestone' in search for ALS treatment

  • On May 7, 2025, Canadian researchers at Sunnybrook Health Sciences Centre started a Phase 1 trial delivering drugs via ultrasound to six ALS patients, including Bill Traynor.
  • The trial addresses the blood-brain barrier, which blocks drug access despite drugs potentially treating ALS, a fatal neurodegenerative disease with no cure.
  • Traynor received immunoglobulin, an antibody therapy that suppresses inflammation, delivered precisely to his motor cortex using focused ultrasound, temporarily opening the barrier.
  • Researchers confirmed the immunoglobulin crossed to the target area and Traynor tolerated the procedure well, though they cautioned the trial is early-stage and not expected to produce treatments.
  • Investigators called this a major milestone enabling future drug testing to target ALS, and Traynor views the study as a source of hope despite his terminal diagnosis.
Insights by Ground AI
Does this summary seem wrong?

8 Articles

All
Left
3
Center
2
Right
1
Winnipeg Free PressWinnipeg Free Press
+4 Reposted by 4 other sources
Center

Canadian researchers reach 'major milestone' in search for ALS treatment

Breaking News, Sports, Manitoba, Canada

·Winnipeg, Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left
50% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

sunnybrook.ca broke the news in on Friday, May 9, 2025.
Sources are mostly out of (0)